Gts Securities »

Akebia Therapeutics shares owned by Gts Securities

Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by Gts Securities from 13F filings

Historical chart of Gts Securities investment in Akebia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akebia Therapeutics held by Gts Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akebia Therapeutics by Gts Securities

Quarter filed Position value Share count Share price at filing
2024-03-31 $178k 97k 1.83
2023-12-31 $102k 82k 1.24
2023-09-30 $90k 79k 1.14
2023-06-30 $16k 18k 0.92

More positions owned by Gts Securities

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
NVIDIA Corporation Put Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Microsoft Corporation Put Option (MSFT)
Meta Platforms Cl A Put Option (META)
Amazon Put Option (AMZN)
Netflix Put Option (NFLX)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Tesla Motors Put Option (TSLA)
Alphabet Cap Stk Cl C Put Option (GOOG)
Apple Put Option (AAPL)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Broadcom Put Option (AVGO)
Advanced Micro Devices Put Option (AMD)
Microstrategy Cl A New Put Option (MSTR)

View all positions for Gts Securities

Top funds holding Akebia Therapeutics

Satter Management
Vanguard Group
Acadian Asset Management
Millennium Management
Susquehanna International
BlackRock
Qube Research & Technologies
Geode Capital Management
Jacobs Levy Equity Management
Goldman Sachs Group
Connor, Clark & Lunn Investment Management
Marshall Wace
Federated Investors
Assenagon Asset Management
Morgan Stanley

View all funds holding Akebia Therapeutics